FDA commissioner Marty Makary says the agency is prioritizing efforts to accelerate drug development timelines beginning at the IND stage, while also pushing to expand OTC drug access.
A rare disease coalition calls on the Trump administration to appoint a new CBER director who understands rare disease drug development and values the views of patients and doctors.
FDA commissioner Marty Makary says the agency is prioritizing efforts to accelerate drug development timelines beginning at the IND stage, while also pushing to expand OTC drug access.
A rare disease coalition calls on the Trump administration to appoint a new CBER director who understands rare disease drug development and values the views of patients and doctors.
Eli Lilly wins FDA approval for Foundayo (orforglipron), a once-daily oral treatment for adults with obesity or those who are overweight with related health conditions.
A Courthouse New Service report outlines the competing arguments made before a three-judge appeals court panel in a case involving FDA’s decision to remove Zepbound, Ozempic, and Wegovy from its shortage list, effectively banning compounded versions of the weight-loss drugs.
